We are developing a state-of-the-art research and innovation hub, specializing in early-stage drug discovery and development, to establish Greece as a critical player in biomedical innovation.
Our mission is to advance early-stage drug discovery and development for the benefit of patients worldwide.
Our goal is to advance drug discovery and development initiatives in Greece, by establishing Athens LifeTech Park as a reference point for the life sciences. Recognizing the importance of physical proximity in fostering an ecosystem, we provide all necessary resources in one location to encourage collaboration and innovation, while connecting with advanced ecosystems worldwide.
Athens LifeTech Park is an ELPEN initiative, designed and executed in collaboration with leading scientists within Greece and internationally.
It operates as a stand-alone, not-for-profit entity (AMKE), overseen by an independent Board of Directors.
The Advisory Committee of Athens LifeTech Park (ALTP) held its first official meeting on March 13, 2025, in New York.
The distinguished Greek scientist Dr. Dimitrios Iliopoulos visited the under-construction “Athens LifeTech Park”, in the context of collaboration that has been developed.
The Vice President of the European Commission for promoting our European Way of Life, Margaritis Schinas, and the Director General of Medicines for Europe, Adrian Van Den Hoven, visited the under construction Athens LifeTech Park in Spata.
We believe Greece has the potential to play a key role in the global life sciences ecosystem by harnessing its exceptional scientific talent.
Join us in shaping the future of health and life sciences - your ideas, expertise, and passion can make a real difference. Get in touch and become part of our journey!
Ελληνικά
English